Krishnappa Janardhan, Ngoh Adeline, Hong Yeo Tong, ChunLiang Chen, Derrick Chan Wei Shih
Paediatric Neurology, Department of Paediatric Medicine, KK Women's and Children's.
Department of Pharmacy, KK Women's and Children's Hospital.
Child Neurol Open. 2021 Oct 23;8:2329048X211046447. doi: 10.1177/2329048X211046447. eCollection 2021 Jan-Dec.
Breath-holding spells are common non-epileptic events with onset between 6 months and 18 months of age that are usually triggered by minor painful events or strong emotions. Symptomatic treatments for breath-holding spells include iron supplementation, glycopyrrolate and piracetam. Hyperekplexia is a rare non-epileptic disorder characterized by generalized hypertonia and exaggerated startle. Prolonged stiffening triggered by startle can lead to desaturation, cardiac asystole and sudden infant death. It is commonly treated with Clonazepam and other anti-epileptic drugs. Piracetam has been reported to be effective in some anecdotal cases. We describe a case of an infant with frequent hyperekplexia-like breath-holding events who failed to respond adequately to glycopyrrolate, pace-maker insertion and clonazepam, who had marked improvement in his symptoms with high dose Piracetam. High dose Piracetam should be considered in infants with similar severe hyperekplexia-like/breath-holding events as it may be beneficial in ameliorating the acute and chronic course in these children.
屏气发作是常见的非癫痫性事件,发病年龄在6个月至18个月之间,通常由轻微疼痛事件或强烈情绪引发。屏气发作的对症治疗包括补充铁剂、格隆溴铵和吡拉西坦。惊吓症是一种罕见的非癫痫性疾病,其特征为全身肌张力亢进和惊吓反应过度。惊吓引发的长时间僵硬可导致血氧饱和度下降、心搏停止和婴儿猝死。该病通常用氯硝西泮和其他抗癫痫药物治疗。据报道,吡拉西坦在一些个别病例中有效。我们描述了一例频繁发生类似惊吓症屏气事件的婴儿,该婴儿对格隆溴铵、起搏器植入和氯硝西泮反应不佳,而高剂量吡拉西坦使其症状明显改善。对于有类似严重惊吓症样/屏气事件的婴儿,应考虑使用高剂量吡拉西坦,因为它可能有助于改善这些儿童的急性和慢性病程。